Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin,  a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.

Market Dynamics

The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.

Key features of the study:

• This report provides an in-depth analysis of the global duck medicine and vaccines market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global duck medicine and vaccines market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global duck medicine and vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global duck medicine and vaccines market

Detailed Segmentation:

• Global Duck Medicine and Vaccines Market, By Type:
  • Medicine
  • Vaccines
• Global Duck Medicine and Vaccines Market, By Application:
  • Farm
  • Application
• Global Duck Medicine and Vaccines Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ceva
  • YEBIO BIOENGINEERING CO., LTD.
  • NAVETCO
  • Shangqiu Meilan Biological Engineering Co.,Ltd.
  • Merck & Co., Inc.
  • EGAVET
  • Bioveta, a.s.
  • Jilin Zhengye Biological Products company limited
  • Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.